GEAR UNIVERSITYLoading…
AVERY FISK · AF COACHING

Androgens

Dehydroepiandrosterone (DHEA)

An endogenous hormone precursor whose rise in blood does not guarantee improved strength, body composition or wellbeing.

Two-year randomized placebo-controlled human trial; evidence checked 2026-10-01

Also known as: DHEA · Prasterone

Dehydroepiandrosterone (DHEA) molecular structure
Structure reference · C19H28O2

Practical use

Evidence interpretation and concrete review questions

Define the actual problem
Low energy, low strength and a low laboratory result are separate findings.
Choose patient-important outcomes
Ask what change in function or symptoms would count as benefit.
Keep products distinct
Record DHEA versus DHEA-S, 1-DHEA and the actual formulation.

DHEA in older adults

PubChem chemical identity; checked October 1, 2026

Overview

Dehydroepiandrosterone, or DHEA, is distinct from its sulfated circulating form, DHEA-S, and from the marketed name 1-DHEA. The randomized evidence below concerns systemic DHEA supplementation in older adults with low baseline hormone measurements.

Risks and limitations

The trial found no major adverse-effect signal, but its size cannot exclude rare harms or establish safety in other populations. Endocrine activity and clinical suitability cannot be inferred from the word natural.

How to read this

Biochemical replacement can succeed while patient-important benefits remain absent. Formulation and indication matter when comparing DHEA research.

Research explained

DHEA in older adults

Who was studied

87 older men and 57 older women entered a double-blind study. Men were assigned DHEA, testosterone or placebo; women DHEA or placebo for two years.

What was found

DHEA-S increased, but DHEA did not significantly improve body composition, strength, aerobic performance, insulin sensitivity or quality of life. Selected bone-density measures increased.

What it cannot establish

Modest sample with low baseline hormone levels. Bone-density changes are not fracture outcomes; findings do not describe every formulation or diagnosis.

Read the original study

A higher laboratory value is not the endpoint

The trial raised DHEA-S without the anticipated broad functional benefits.

Supporting source

Similar shorthand can conceal a different steroid

1-DHEA is not ordinary DHEA; matching the full chemical identity prevents a false comparison.

Supporting source

Claims versus findings

Not supported

Restoring a youthful hormone level necessarily reverses aging.

This trial did not demonstrate broad physical or wellbeing improvements.

Check the evidence

Common questions

Did the study prove no possible medical role for any DHEA formulation?

No. Its population and systemic treatment question were specific.

Source

Sources

DHEA in older adults

PubChem chemical identity; checked October 1, 2026

Sources checked 2026-10-01.

General education; not a personal treatment plan.